AI
The two South Korean tech firms have signed an agreement for AI integration.
Kheiron Medical Technologies will distribute its Mia, or “mammography intelligent assessment” in the GCC region via a new partnership with Atlas Medical.
They are also seeking ways to improve high blood pressure management.
The startup, known for its ring-type heart-monitoring device, recently raised $20 million in a Series B funding round.
KT will also open its digital healthcare platform for NeuroSigma's advanced monitoring and AI analysis services.
The model showed 86% sensitivity and a specificity of up to 96.1%.
The technology can detect 588 common and rare skin conditions in 133 categories.
The partnership will use Ada Health's AI-based platform to speed up the diagnosis of rare conditions.
The partnership will work on a drug discovery programme for the genetic muscle wasting disorder.
The company states that the study was designed to minimise bias in assessing the solution’s impact on diagnostic accuracy.